---
source_image: "legal-filing+scanned-document+affidavit+court-document__EFTA01377779_20260130_p001_i001.png"
source_pdf: "EFTA01377779.pdf"
method: pdf_text
words: 801
confidence: 1.00
extracted: 2026-02-13T17:09:19.038515
---

S- /A 
(except if permitted to do so under the laws of Hong Kong) other than with respect to shares which are or are intended to be 
disposed of only to persons outside Hong Kong or only to "professional investors" within the meaning of the Securities and Futures 
Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder. 
Singapore 
This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this 
prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the 
shares may not be circulated or distributed, nor may the shares be offered or sold or be made the subject of an invitation for 
subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under 
Section 274 of the Securities and Futures Act. Chapter 289 of Singapore (the SFA), (ii) to a relevant person, or any person 
pursuant to Section 275(1A), and in accordance with the conditions, specified in Section 275 of the SFA or (iii) otherwise pursuant 
to. and in accordance with the conditions of, any other applicable provision of the SFA. 
Where the shares are subscribed or purchased under Section 275 by a relevant person which is: (a) a corporation (which is 
not an accredited investor) the sole business of which is to hold investments and the entire share capital of which is owned by one 
or more individuals, each of whom is an accredited investor; or (b) a trust (where the trustee is not an accredited investor) whose 
sole purpose is to hold investments and each beneficiary is an accredited investor, shares, debentures, and units of shares and 
debentures of that corporation or the beneficiaries' rights and interest in that trust shall not be transferable for six months after that 
corporation or that trust has acquired the shares under Section 275 except: (1) to an institutional investor under Section 274 of the 
SFA or to a relevant person, or any person pursuant to Section 275(1A), and in accordance with the conditions, specified in 
Section 275 of the SFA; (2) where no consideration is given for the transfer; or (3) by operation of law. 
Japan 
The securities have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (the 
Financial Instruments and Exchange Law) and the securities may not be offered or sold, directly or indirectly, in Japan or to, or for 
the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or 
other entity organized under the laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to a resident 
of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial 
Instruments and Exchange Law and any other applicable laws, regulations, and ministerial guidelines of Japan. 
Canada 
The securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are 
accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act 
(Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing 
Registrant Obligations. Any resale of the securities must be made in accordance with an exemption from, or in a transaction not 
subject to, the prospectus requirements of applicable securities laws. 
195 
Table of (:ontenbt 
Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or 
damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for 
rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser's 
province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser's province 
or territory for particulars of these rights or consult with a legal advisor. 
Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required 
to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering. 
The underwriters do not expect sales to discretionary accounts to exceed five percent of the total number of shares offered. 
We estimate that our share of the total expenses of the offering, excluding underwriting discounts and commissions, will be 
approximately $7.0 million. We have agreed to reimburse the underwriters for certain expenses in an amount up to 555,000. 
We and the selling stockholder have agreed to indemnify the several underwriters against certain liabilities, including 
http://www..tv.gov/Archivestedgar/data/1512673APOI 19312515369092/d937622dsl a.htnil 11/6/2015 7:37:12 AM] 
CONFIDENTIAL - PURSUANT TO FED. R. GRIM. P. 6(e) 
CONFIDENTIAL 
DB-SDNY-0074931 
SDNY_GM_00221115 
EFTA01377779
